Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(20):1573-1574; doi:10.1093/jnci/93.20.1573
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Wiesner, G. L.
Right arrow Articles by Markowitz, S. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wiesner, G. L.
Right arrow Articles by Markowitz, S. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 20, 1573-1574, October 17, 2001
© 2001 Oxford University Press

CORRESPONDENCE

RESPONSE: Testing for Colon Neoplasia Susceptibility Variants at the Human COX2 Locus

Georgia L. Wiesner, Petra Platzer, Sarah G. Buxbaum, Susan Lewis, Melissa Macmillen, Joseph Willis, Aravinda Chakravarti, Robert C. Elston, Sanfor D. Markowitz

Affiliations of authors: G. L. Wiesner, Departments of Genetics and Medicine, Center for Human Genetics, and Ireland Comprehensive Cancer Center, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH; P. Platzer, S. D. Markowitz, Department of Medicine and Ireland Comprehensive Cancer Center, Case Western Reserve University and University Hospitals of Cleveland, and Howard Hughes Medical Institute, Cleveland; S. G. Buxbaum, R. C. Elston, Department of Epidemiology and Biostatistics and Ireland Cancer Center, Case Western Reserve University; S. Lewis, M. MacMillen, Department of Genetics and the Center for Human Genetics, Case Western Reserve University and University Hospitals of Cleveland; J. Willis, Department of Pathology and Ireland Comprehensive Cancer Center, Case Western Reserve University and University Hospitals of Cleveland; A. Chakravarti, McKusick-Nathans Institute of Genetic Medicine, The Johns Hopkins University, Baltimore, MD.

Correspondence to: Sanford D. Markowitz, M.D., Ph.D., 11001 Cedar Rd., Rm. 200, Cleveland, OH 44106 (e-mail: sxm10@po.cwru.edu).

We thank Drs. Ulrich and Potter for their thoughtful comments and appreciate the opportunity to clarify any potential misconceptions regarding our recent study (1).

Drs. Ulrich and Potter express the concern that the population we studied includes individuals at low risk (small adenomas) but also is a group . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?